Sort
141,003 grants matching “cytokine”
Oral Infections and Vascular Disease Epidemiology Study (INVEST)
$1,333,221Moise Desvarieux · Columbia University Health Sciences · R01 · FY2008 · DE
Early Events in Alzheimer Pathogenesis
$1,332,951University Of Arkansas Med Scis Ltl Rock · P01 · FY2004 · AG
Generation of Hematopoietic Stem and Progenitor Cells from Human iPSCs
$1,332,597Andre Larochelle · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL
Gene Therapy for Inherited Blood Disorders
$1,332,597Andre Larochelle · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL
PATHOLOGICAL, BIOCHEMICAL CHANGES OF THERMAL INJURY
$1,332,397University Of Texas Sw Med Ctr/Dallas · P50 · FY2003 · GM
Dendritic Cell Biology and Therapy
$1,332,338Olivera J Finn · University Of Pittsburgh At Pittsburgh · P01 · FY2008 · CA
Post-Transcriptional Regulation of Interleukin-7 Receptor Expression
$1,332,212Jung-Hyun Park · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
HIV Exposed Uninfected Infant Cohort Study
$1,331,213Donald M Thea · Boston University Medical Campus · R01 · FY2019 · HD
TLR Signal Inhibition: A Novel Therapeutic Paradigm
$1,330,773Leonard D Kohn · Interthyr Corporation · R42 · FY2009 · AI
Role of mitochondria in neurodegenerative diseases
$1,330,740Richard Youle · National Institute Of Neurological Disorders And Stroke · ZIA · FY2018 · NS
Translational Studies in Progressive Multifocal Leukoencephalopathy
$1,330,691Irene Cortese · National Institute Of Neurological Disorders And Stroke · ZIA · FY2022 · NS
Retinal Ganglion Cell Replacement in Clinically Relevant Models of Optic Neuropathy
$1,330,471Tonia S Rex · Vanderbilt University Medical Center · U24 · FY2022 · EY
Novel Targets for Immunotherapy
$1,330,078Claudia Palena · Division Of Basic Sciences - Nci · ZIC · FY2020 · CA
Translational Applications of mda-7/IL-24 in Cancer
$1,329,682Paul B Fisher · Virginia Commonwealth University · P01 · FY2008 · CA
VIPS: Vascular Effects of Infection in Pediatric Stroke
$1,329,546Heather J Fullerton · University Of California, San Francisco · R01 · FY2009 · NS
Clinical Development of Novel Therapies for Acute Lymphoblastic Leukemia
$1,329,439Nirali Shah · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Interaction between Interleukin-6 (IL-6) and the growth hormone
$1,328,915Gregory R. Adams · University Of California-Irvine · P01 · FY2007 · HD
Synthetic microparticle malaria vaccine
$1,328,587Thomas J Powell · Artificial Cell Technologies, Inc. · R44 · FY2015 · AI
Danger 1: initiating and stopping immune responses
$1,328,365Polly C Matzinger · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
MODULATION OF EFFECTOR T CELLS IN DIABETES
$1,328,138Scripps Research Institute · P01 · FY2001 · DK
MODULATION OF EFFECTOR T CELLS IN DIABETES
$1,328,138Scripps Research Institute · P01 · FY2000 · DK
IL-27R signaling as a negative regulator of innate and adaptive anti-cancer immunity in hepatocellular carcinoma
$1,327,850Ekaterina Koltsova · Cedars-Sinai Medical Center · R01 · FY2025 · CA
Studies of Receptor Interactions and Effects of Alarmins
$1,327,663Joost J Oppenheim · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Innate Immunity End Experimental Crohn's Disease
$1,327,589Fabio Cominelli · Case Western Reserve University · P01 · FY2014 · DK
Obesity, related comorbidities, and breast cancer outcomes in African Americans
$1,327,573Elisa V Bandera · Rbhs -Cancer Institute Of New Jersey · R01 · FY2017 · CA